Vitorović-Todorović MD - Search Results

1

(E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization.

Vitorović-Todorović MD, Erić-Nikolić A, Kolundžija B, Hamel E, Ristić S, Juranić IO, Drakulić BJ. Vitorović-Todorović MD, et al. Eur J Med Chem. 2013 Apr;62:40-50. doi: 10.1016/j.ejmech.2013.01.006. Epub 2013 Jan 11. Eur J Med Chem. 2013. PMID: 23353745 Free PMC article.

2

4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.

Vitorović-Todorović MD, Juranić IO, Mandić LM, Drakulić BJ. Vitorović-Todorović MD, et al. Bioorg Med Chem. 2010 Feb;18(3):1181-93. doi: 10.1016/j.bmc.2009.12.042. Epub 2009 Dec 22. Bioorg Med Chem. 2010. PMID: 20061157

3

Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.

Vitorović-Todorović MD, Koukoulitsa C, Juranić IO, Mandić LM, Drakulić BJ. Vitorović-Todorović MD, et al. Eur J Med Chem. 2014 Jun 23;81:158-75. doi: 10.1016/j.ejmech.2014.05.008. Epub 2014 May 4. Eur J Med Chem. 2014. PMID: 24836068

4

The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models.

Vitorović-Todorović MD, Cvijetić IN, Juranić IO, Drakulić BJ. Vitorović-Todorović MD, et al. J Mol Graph Model. 2012 Sep;38:194-210. doi: 10.1016/j.jmgm.2012.08.001. Epub 2012 Sep 1. J Mol Graph Model. 2012. PMID: 23073222

5

Weak intermolecular interactions in 11-chloro-2,3,4,5-tetrahydro-1H-cyclohepta[b]quinoline.

Novaković SB, Vitorović-Todorović MD, Bogdanović GA, Drakulić BJ. Novaković SB, et al. Among authors: vitorovic todorovic md. Acta Crystallogr C. 2008 Sep;64(Pt 9):o502-4. doi: 10.1107/S0108270108022221. Epub 2008 Aug 13. Acta Crystallogr C. 2008. PMID: 18758020

6

The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents.

Vitorović-Todorović MD, Worek F, Perdih A, Bauk SĐ, Vujatović TB, Cvijetić IN. Vitorović-Todorović MD, et al. Chem Biol Interact. 2019 Aug 25;309:108714. doi: 10.1016/j.cbi.2019.06.027. Epub 2019 Jun 19. Chem Biol Interact. 2019. PMID: 31228470

7

Molecular recognition of acetylcholinesterase and its subnanomolar reversible inhibitor: a molecular simulations study.

Vitorović-Todorović M, Cvijetić I, Zloh M, Perdih A. Vitorović-Todorović M, et al. J Biomol Struct Dyn. 2022 Mar;40(4):1671-1691. doi: 10.1080/07391102.2020.1831960. Epub 2020 Oct 13. J Biomol Struct Dyn. 2022. PMID: 33047663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters